First Time Loading...

Intersect Ent Inc
NASDAQ:XENT

Watchlist Manager
Intersect Ent Inc Logo
Intersect Ent Inc
NASDAQ:XENT
Watchlist
Price: 28.24 USD Market Closed
Updated: Jun 1, 2024

Intersect Ent Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Intersect Ent Inc
Total Current Liabilities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Intersect Ent Inc
NASDAQ:XENT
Total Current Liabilities
$46.4m
CAGR 3-Years
32%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Current Liabilities
$7.3B
CAGR 3-Years
11%
CAGR 5-Years
1%
CAGR 10-Years
14%
Boston Scientific Corp
NYSE:BSX
Total Current Liabilities
$4.9B
CAGR 3-Years
13%
CAGR 5-Years
2%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Total Current Liabilities
$7B
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Total Current Liabilities
$14B
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Liabilities
$1.4B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Intersect Ent Inc's Total Current Liabilities?
Total Current Liabilities
46.4m USD

Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Total Current Liabilities amounts to 46.4m USD.

What is Intersect Ent Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
30%

Over the last year, the Total Current Liabilities growth was 7%. The average annual Total Current Liabilities growth rates for Intersect Ent Inc have been 32% over the past three years , 30% over the past five years .